PEGylated Liposomal Nanocarriers in Cancer Therapy: Emerging Strategies and Clinical Prospects.

Kumar A, Islam MM, Judder MI, Jain H, Kumar N

Open source

DOI
10.2174/0126673878471991260809200127
Published
2026 Aug 24
Container
Recent advances in drug delivery and formulation
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2174/0126673878471991260809200127,
  title = {PEGylated Liposomal Nanocarriers in Cancer Therapy: Emerging Strategies and Clinical Prospects.},
  author = {Kumar A and Islam MM and Judder MI and Jain H and Kumar N},
  year = {2026},
  journal = {Recent advances in drug delivery and formulation},
  doi = {10.2174/0126673878471991260809200127},
  url = {https://doi.org/10.2174/0126673878471991260809200127}
}

RIS

TY  - JOUR
TI  - PEGylated Liposomal Nanocarriers in Cancer Therapy: Emerging Strategies and Clinical Prospects.
AU  - Kumar A
AU  - Islam MM
AU  - Judder MI
AU  - Jain H
AU  - Kumar N
PY  - 2026
JO  - Recent advances in drug delivery and formulation
DO  - 10.2174/0126673878471991260809200127
UR  - https://doi.org/10.2174/0126673878471991260809200127
ER  - 

APA

A, K., MM, I., MI, J., H, J., & N, K. (2026). PEGylated Liposomal Nanocarriers in Cancer Therapy: Emerging Strategies and Clinical Prospects.. Recent advances in drug delivery and formulation. https://doi.org/10.2174/0126673878471991260809200127

Source records